Stroke recovery trial pulled before it even started
NCT ID NCT05367362
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study planned to test whether adding the antibiotic minocycline to standard stroke treatment could improve recovery in people who had a severe stroke. It was designed as a small, early-phase trial with about 40 participants, but it was withdrawn before enrolling anyone. Because no data were collected, we don't know if minocycline would have helped or not.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Minocycline (an antibiotic that may also protect brain cells)
- What this could lead to
- If it had worked, this could have pointed toward a simple add-on treatment to improve recovery after a severe stroke.
- What could go wrong
- The trial was withdrawn before any patients were enrolled, so we have no results. Even if it had run, it was a small, early-phase study, so success was far from guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?